Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adrenergic receptors, also known as adrenoceptors, are a class of G protein-coupled receptors that mediate the physiological responses to the catecholamines epinephrine and norepinephrine [2, 5, 8]. They are integral components of the sympathetic nervous system, categorized into alpha (alpha-1, alpha-2) and beta (beta-1, beta-2, beta-3) subtypes based on their pharmacological profiles and signaling pathways [1, 8, 12]. Epinephrine serves as a primary endogenous ligand, acting as a non-selective agonist that triggers diverse effects such as increased heart rate, bronchodilation, and peripheral vasoconstriction [3, 6, 10]. These receptors are critical therapeutic targets; agonists like epinephrine are life-saving in anaphylaxis and cardiac arrest, while antagonists (beta-blockers and alpha-blockers) are widely used to manage hypertension and chronic heart failure [1, 8]. Understanding the subtype-specific distribution and signaling is essential for developing selective drugs that minimize off-target effects [12].
Agonism or antagonism of alpha and beta-adrenergic receptors to modulate sympathetic nervous system activity, affecting smooth muscle contraction, heart rate, and metabolic rate.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic receptor (ADR) (ADR).